NYSE : AVTR

Avantor, Inc.

$11.2 USD

-$0.09 (-0.8%)

Volume
10.3M
Average Volume
9.67M
Market Capitalization
$7.65B
P/E Ratio
-13.93
Dividend Yield
0.00%
Price Target
$9.50
Year High
$15.93
Year Low
$7.27
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.76
Source Headline
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?

Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com - 2026-07-15 13:10:28

Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership

AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.

zacks.com - 2026-07-15 10:05:24

Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product

RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion of a collaboration between its NuSil® brand, a premier global manufacturer of high-purity silicones suitable for use in medical devices and drug-device combination products, and the Population Council, an international nonprofit research organization, to support the development of the Council's new three-month dapivirine vaginal ring for HIV prevention.

prnewswire.com - 2026-07-14 08:05:00

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

zacks.com - 2026-07-09 14:25:35

Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.

prnewswire.com - 2026-07-01 08:05:00

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-29 12:32:10

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

zacks.com - 2026-05-29 12:11:05

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.

prnewswire.com - 2026-05-19 06:05:00

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.

zacks.com - 2026-04-30 13:40:36

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.

seekingalpha.com - 2026-04-30 13:03:16

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-29 13:12:00

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.

zacks.com - 2026-04-29 08:46:37

Avantor® Reports First Quarter 2026 Results

Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.

prnewswire.com - 2026-04-29 06:05:00

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

RADNOR, Pa., April 23, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026.

prnewswire.com - 2026-04-23 17:05:00

Avantor Expands Masterflex Portfolio to Streamline Bioprocessing

AVTR expands Masterflex across its fluid handling portfolio, aiming to streamline workflows and boost scalable bioprocessing adoption.

zacks.com - 2026-04-22 13:41:07

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders.

globenewswire.com - 2026-04-22 09:32:00

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing Company to attend INTERPHEX 2026 in New York City from April 21-23 RADNOR, Pa., April 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, today announced the expansion of its Masterflex brand across its fluid handling portfolio, bringing together standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems.

prnewswire.com - 2026-04-21 08:05:00

Longleaf Partners Fund Q1 2026 Contributors And Detractors

During the quarter, we had no new purchases and exited three holdings: Louisiana-Pacific, PayPal and Walt Disney. CNH, a leading global agriculture and construction equipment manufacturer, was a contributor for the quarter. Life-sciences company Avantor detracted for the quarter.

seekingalpha.com - 2026-04-16 08:10:00

Get AVTR Insider Trade Alerts

AVTR Price Target Summary

Last Month

$9.67

3 analysts

Last Quarter

$9.00

5 analysts

Last Year

$10.33

20 analysts

All Time

$21.30

42 analysts

AVTR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-08 Citigroup Maintain Neutral Neutral
2026-07-06 Evercore ISI Group Maintain In Line In Line
2026-06-24 Barclays Maintain Underweight Underweight
2026-04-30 Evercore ISI Group Maintain In Line In Line
2026-04-30 Citigroup Maintain Neutral Neutral
2026-04-15 Barclays Maintain Underweight Underweight
2026-04-06 Evercore ISI Group Maintain In Line In Line
2026-03-06 Barclays Downgrade Equal Weight Underweight
2026-02-13 Wells Fargo Maintain Overweight Overweight
2026-02-12 Barclays Maintain Equal Weight Equal Weight
2026-02-12 Citigroup Maintain Neutral Neutral
2026-01-07 TD Cowen Maintain Hold Hold
2026-01-05 Evercore ISI Group Downgrade Outperform In Line
2025-12-17 Jefferies Downgrade Hold Underperform
2025-10-30 Evercore ISI Group Maintain Outperform Outperform
2025-10-30 JP Morgan Downgrade Overweight Neutral
2025-10-30 Barclays Downgrade Overweight Equal Weight
2025-10-24 Baird Maintain Outperform Outperform
2025-10-16 Raymond James Maintain Outperform Outperform
2025-10-02 Barclays Maintain Overweight Overweight
2025-08-04 JP Morgan Maintain Overweight Overweight
2025-08-04 Raymond James Maintain Outperform Outperform
2025-08-04 Baird Maintain Outperform Outperform
2025-08-04 Morgan Stanley Maintain Equal Weight Equal Weight
2025-08-04 Barclays Maintain Overweight Overweight
2025-08-04 RBC Capital Maintain Outperform Outperform
2025-08-04 Stifel Maintain Hold Hold
2025-08-04 Evercore ISI Group Maintain Outperform Outperform
2025-08-04 Wells Fargo Maintain Overweight Overweight
2025-07-28 Baird Maintain Outperform Outperform
2025-04-29 Goldman Sachs Downgrade Buy Neutral
2025-04-28 Stifel Downgrade Buy Hold
2025-04-28 Baird Maintain Outperform Outperform
2025-04-28 Barclays Maintain Overweight Overweight
2025-04-28 Morgan Stanley Downgrade Overweight Equal Weight
2025-04-28 RBC Capital Maintain Outperform Outperform
2025-04-17 Wells Fargo Maintain Overweight Overweight
2025-04-10 Barclays Maintain Overweight Overweight
2025-03-04 Citigroup Maintain Neutral Neutral
2025-02-10 Morgan Stanley Maintain Overweight Overweight
2025-02-10 Raymond James Maintain Outperform Outperform
2025-02-10 Wells Fargo Maintain Overweight Overweight
2025-02-10 RBC Capital Maintain Outperform Outperform
2025-02-10 Stifel Maintain Buy Buy
2025-02-10 Barclays Maintain Overweight Overweight
2025-02-03 Barclays Maintain Overweight Overweight
2025-01-21 Raymond James Maintain Outperform Outperform
2025-01-17 UBS Downgrade Buy Neutral
2024-10-28 Baird Maintain Outperform Outperform
2024-10-28 Wells Fargo Maintain Overweight Overweight
2024-10-25 Barclays Maintain Overweight Overweight
2024-10-08 UBS Maintain Buy Buy
2024-09-26 RBC Capital Maintain Outperform Outperform
2024-07-29 Morgan Stanley Maintain Overweight Overweight
2024-07-29 Baird Maintain Outperform Outperform
2024-07-29 RBC Capital Maintain Outperform Outperform
2024-07-29 Stifel Maintain Buy Buy
2024-07-29 TD Cowen Maintain Buy Buy
2024-07-29 Barclays Maintain Overweight Overweight
2024-07-15 RBC Capital Maintain Outperform Outperform
2024-07-10 Citigroup Downgrade Buy Neutral
2024-07-02 Evercore ISI Group Maintain Outperform Outperform
2024-06-28 Barclays Maintain Overweight Overweight
2024-04-29 Baird Maintain Outperform Outperform
2024-04-18 Deutsche Bank Maintain Hold Hold
2024-04-10 Barclays Maintain Overweight Overweight
2024-04-04 Evercore ISI Group Maintain Outperform Outperform
2024-02-15 UBS Maintain Buy Buy
2024-02-15 Barclays Maintain Overweight Overweight
2024-02-15 Baird Maintain Outperform Outperform
2024-02-15 Citigroup Maintain Buy Buy
2024-02-15 JP Morgan Maintain Overweight Overweight
2024-02-15 RBC Capital Maintain Outperform Outperform
2024-01-26 Raymond James Maintain Outperform Outperform
2024-01-09 RBC Capital Maintain Outperform Outperform
2024-01-04 Evercore ISI Group Upgrade In Line Outperform
2023-12-12 Deutsche Bank Maintain Hold Hold
2023-12-11 Barclays Maintain Overweight Overweight
2023-12-11 TD Cowen Upgrade Market Perform Outperform
2023-12-07 Goldman Sachs Maintain Buy Buy
2023-10-30 Barclays Maintain Overweight Overweight
2023-10-30 Raymond James Maintain Outperform Outperform
2023-10-30 Morgan Stanley Maintain Overweight Overweight
2023-09-29 Barclays Maintain Overweight Overweight
2023-08-01 Morgan Stanley Maintain Overweight Overweight
2023-07-31 B of A Securities Maintain Buy Buy
2023-07-31 Morgan Stanley Maintain Overweight Overweight
2023-07-31 Credit Suisse Maintain Neutral Neutral
2023-07-31 Barclays Maintain Overweight Overweight
2023-07-31 William Blair Downgrade Outperform Market Perform
2023-07-31 RBC Capital Maintain Outperform Outperform
2023-07-31 Baird Maintain Outperform Outperform
2023-07-31 Evercore ISI Group Downgrade Outperform In Line
2023-07-31 Raymond James Maintain Outperform Outperform
2023-07-06 Evercore ISI Group Maintain Outperform Outperform
2023-05-01 Raymond James Maintain Outperform Outperform
2023-05-01 Baird Maintain Outperform Outperform
2023-05-01 Morgan Stanley Maintain Overweight Overweight
2023-05-01 Barclays Maintain Overweight Overweight
2023-04-30 B of A Securities Maintain Buy Buy
2023-04-04 Barclays Maintain Overweight Overweight
2023-04-04 Evercore ISI Group Maintain Outperform Outperform
2023-02-08 Wells Fargo Maintain Overweight Overweight
2023-02-06 Baird Maintain Outperform Outperform
2023-02-06 Citigroup Maintain Buy Buy
2023-02-06 Raymond James Maintain Outperform Outperform
2023-02-03 Evercore ISI Group Maintain Outperform Outperform
2023-01-24 Barclays Maintain Overweight Overweight
2023-01-10 Wells Fargo Maintain Overweight Overweight
2022-12-14 Deutsche Bank Maintain Hold Hold
2022-10-31 Morgan Stanley Maintain Overweight Overweight
2022-10-31 Raymond James Maintain Outperform Outperform
2022-10-31 Barclays Maintain Overweight Overweight
2022-10-31 Baird Maintain Outperform Outperform
2022-10-31 Credit Suisse Maintain Neutral Neutral
2022-10-31 Wells Fargo Maintain Overweight Overweight
2022-10-25 Morgan Stanley Maintain Overweight Overweight
2022-10-18 Raymond James Maintain Outperform Outperform
2022-10-13 Goldman Sachs Maintain Buy Buy
2022-10-06 Barclays Maintain Overweight Overweight
2022-10-06 Baird Maintain Outperform Outperform
2022-10-05 Citigroup Upgrade Neutral Buy
2022-09-15 Keybanc Maintain Overweight Overweight
2022-09-14 Cowen & Co. Downgrade Outperform Market Perform
2022-09-14 Citigroup Maintain Neutral Neutral
2022-09-12 Barclays Maintain Overweight Overweight
2022-09-09 Cleveland Research Downgrade Buy Neutral
2022-08-25 Credit Suisse Maintain Neutral Neutral
2022-08-01 Baird Maintain Outperform Outperform
2022-08-01 Citigroup Maintain Neutral Neutral
2022-08-01 Barclays Maintain Overweight Overweight
2022-08-01 Morgan Stanley Maintain Overweight Overweight
2022-08-01 Raymond James Maintain Outperform Outperform
2022-07-14 Goldman Sachs Maintain Buy Buy
2022-07-14 Barclays Maintain Overweight Overweight
2022-05-02 Morgan Stanley Maintain Overweight Overweight
2022-04-25 Wells Fargo Maintain Overweight Overweight
2022-04-18 Evercore ISI Group Maintain Outperform Outperform
2022-04-18 Raymond James Maintain Outperform Outperform
2022-04-04 Evercore ISI Group Maintain Outperform Outperform
2022-04-04 Citigroup Downgrade Buy Neutral
2022-02-07 Barclays Maintain Overweight Overweight
2022-02-07 Morgan Stanley Maintain Overweight Overweight
2022-02-07 Raymond James Maintain Outperform Outperform
2022-01-27 Barclays Maintain Overweight Overweight
2021-11-01 Raymond James Maintain Outperform Outperform
2021-11-01 Barclays Maintain Overweight Overweight
2021-09-10 Stifel Maintain Buy Buy
2021-09-10 Credit Suisse Maintain Outperform Outperform
2021-09-09 Keybanc Maintain Overweight Overweight
2021-09-09 Evercore ISI Group Maintain Outperform Outperform
2021-08-02 Morgan Stanley Maintain Overweight Overweight
2021-08-02 Piper Sandler Upgrade Neutral Overweight
2021-07-30 Keybanc Maintain Overweight Overweight
2021-07-30 Credit Suisse Maintain Outperform Outperform
2021-07-30 Wells Fargo Maintain Overweight Overweight
2021-06-04 Goldman Sachs Maintain Buy Buy
2021-04-29 Credit Suisse Maintain Outperform Outperform
2021-04-29 Morgan Stanley Maintain Overweight Overweight
2021-04-29 Raymond James Maintain Outperform Outperform
2021-04-29 Stifel Upgrade Hold Buy
2021-03-03 Barclays Maintain Overweight Overweight
2021-02-04 Credit Suisse Maintain Outperform Outperform
2021-02-04 Morgan Stanley Maintain Overweight Overweight
2021-01-19 KeyBanc Maintain Overweight Overweight
2021-01-18 Keybanc Maintain Overweight Overweight
2021-01-12 Raymond James Maintain Outperform Outperform
2020-11-10 KeyBanc Upgrade Sector Weight Overweight
2020-11-10 Keybanc Upgrade Sector Weight Overweight
2020-10-29 Morgan Stanley Maintain Overweight Overweight
2020-10-28 Wells Fargo Maintain Overweight Overweight
2020-10-12 Raymond James Maintain Outperform Outperform
2020-10-09 Jefferies Maintain Buy Buy
2020-09-14 Morgan Stanley Maintain Overweight Overweight
2020-07-30 Stifel Maintain Hold Hold
2020-07-30 Raymond James Maintain Outperform Outperform
2020-07-30 Piper Sandler Maintain Neutral Neutral
2020-07-28 Credit Suisse Maintain Outperform Outperform
2020-07-15 Cleveland Research Upgrade Neutral Buy
2020-04-30 Stifel Maintain Hold Hold
2020-04-30 Credit Suisse Maintain Outperform Outperform
2020-04-30 UBS Maintain Buy Buy
2020-04-30 Citigroup Maintain Buy Buy
2020-04-30 Raymond James Maintain Outperform Outperform
2020-04-28 UBS Maintain Buy Buy
2020-04-02 Stifel Maintain Hold Hold
2020-03-26 Barclays Maintain Overweight Overweight
2020-03-20 Citigroup Maintain Buy Buy
2020-02-10 Raymond James Maintain Outperform Outperform
2020-01-08 Wells Fargo Maintain Overweight Overweight
2019-11-15 Stifel Nicolaus Maintain Hold Hold
2019-06-14 Janney Capital Maintain Buy Buy
2019-06-12 Raymond James Maintain Outperform Outperform
2019-06-11 Barclays Maintain Overweight Overweight
2019-06-11 Deutsche Bank Maintain Buy Buy
2019-06-11 JP Morgan Maintain Overweight Overweight
2019-06-11 Goldman Sachs Maintain Buy Buy
2019-06-11 Jefferies Maintain Buy Buy
2019-06-11 KeyBanc Maintain Sector Weight Equal Weight
2019-06-11 Credit Suisse Maintain Outperform Outperform
2019-06-11 Baird Maintain Outperform Outperform
2019-06-11 UBS Maintain Buy Buy
2019-06-11 Citigroup Maintain Buy Buy
2019-06-11 Piper Jaffray Maintain Neutral Neutral